Revista de la Facultad de Medicina UNAM

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Revista de la Facultad de Medicina UNAM >Year 2011, Issue 6

Pulido PVM, Ávalos GJM, Pliego RCL
Low association between non-alcoholic fatty liver disease and cardiovascular risk in patients with metabolic syndrome
Rev Fac Med UNAM 2011; 54 (6)

Language: Espańol
References: 13
Page: 9-12
PDF: 141.74 Kb.

Full text


Introduction: Metabolic síndrome (MS) is a group of abnormalities which favor the development of cardiovascular, hepatic, and degenerative complications; frequently showing a subclinical evolution. Non-alcoholic fatty liver (NAFL), featured by hepatic fat accumulation, is a common condition among patients with MS. It has been associated with cardiovascular risk, suggesting a predictive role.
Material and methods: A cross sectional, comparative, observational study was carried out with the approval of the Institutional Ethics Committee. Patients with MS from the Internal Medicine Department, Hospital General Regional “Lic. Adolfo López Mateos ”, ISSSTE, were included. Patients were not consuming hepatotoxic drugs or alcohol intake higher than 30 grams a day. After informed consent was signed, the following studies were obtained: clinical data, liver function tests, lipids profile and hepatic echography. With this information it was possible to determine the presence of NAFL and cardiovascular risk, assessed by the atherogenic index and risk scale (euro-score). Results. Fifty five patients were studied, mean age 47.4 ± 11.8 years old. The prevalence of NAFL was 36%, a third from which showed high cardiovascular risk. NAFL was not significantly associated with cardiovascular risk (whole relative risk [RR]=0.5, IC95%=0.23-1.26, p=0.1; atherogenic index RR= .82, CI95%=0.48-1.41, p=0.3, and euro-score RR=0.48, IC95%= 0.15-1.51, p=0.1) there was neither significant correlation with other variables (multiple regression associated to body mass index, p=0.44; triacyglycerides, p=0.32).
Conclusion: We found a low association between NAFL and cardiovascular risk, assessed by atherogenic index and clinical scale; nevertheless, the influence of age, sex, body mass index, and dyslipidemia is not ruled out.

Key words: Metabolic syndrome, non-alcoholic fatty liver, cardiovascular risk.


  1. Alberti FG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-53.

  2. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Cholesterol. JAMA. 2001;285(19):2486-97.

  3. Arslan U, Türkoğlu S, Balcioğlu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007;18(6):433-6.

  4. Treeprasertsuk S, Lopez-Jimenez F, Lindor KD. Nonalcoholic Fatty Liver Disease and the Coronary Artery Disease. Dig Dis Sci. 2010 May 13.

  5. Utzschneide KM, Kahn SE. Review: The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab. 2006;91:4753-61.

  6. Angulo P. Non Alcoholic fatty liver disease. Rev Gastroenterol Mex. 2005;70 Suppl 3:52-6.

  7. Angulo P. Obesity and Nonalcoholic Fatty Liver Disease. Nutr Rev. 2007;65(6 Pt 2):S57-63.

  8. Videla LA, Rodrigo R, Araya J and Poniachik J. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol Med. 2006;12(12): 555-8.

  9. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, Valles V, Ríos- Torres JM, Franco A, et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res. 2004;35(1):76-81.

  10. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J, 2003;24(11):987-1003.

  11. Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: Association with liver fibrosis. Atherosclerosis, 2010 Feb 7.

  12. Adams LA, Harmsen S, St Sauver JL, Charatcharoenwitthaya P, Enders FB, Therneau T, et al. Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study. Am J Gastroenterol. 2010 Feb 9.

  13. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):155-61.

>Journals >Revista de la Facultad de Medicina UNAM >Year 2011, Issue 6

· Journal Index 
· Links 

Copyright 2019